WUXI BIOLOGICS (CAYMAN) INC earnings per share and revenue

2269 earnings per share for the last semiannual are 0.34 HKD whereas the estimation was 0.28 HKD which accounts for 22.00% surprise. Företagets omsättning för samma period uppgår till 9.40 B HKD trots den uppskattade siffran 9.23 B HKD. Estimated earnings per share for the next semiannual are 0.47 HKD, and revenue is expected to reach 8.67 B HKD. Also watch annual changes over time to get a bigger picture of 2269 earnings per share and revenue dynamics.